Study compares long-term effectiveness of diabetes drugs

Researchers at the School of Medicine are comparing the long-term benefits and risks of four widely used diabetes drugs given in combination with metformin, the most commonly prescribed medication for treating type 2 diabetes. The principal investigator at the St. Louis clinical site is Janet B. McGill, MD, who is pictured discussing options with study patient Michael Gingrich.